An introduction to the free radical hypothesis in Parkinson's disease

Superoxide Dismutase

McCord, J. M., & Fridovich, I. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63504-5 · Cited by 12,952 · see citing works

Oxygen toxicity, oxygen radicals, transition metals and disease

Halliwell, B., & Gutteridge, J. M. C. (1984) · Biochemical Journal · doi:10.1042/bj2190001 · Cited by 5,330 · see citing works

Mitochondrial DNA and human evolution

Cann, R. L., Stoneking, M., & Wilson, A. C. (1987) · Nature · doi:10.1038/325031a0 · Cited by 3,100 · see citing works

Oxygen free radicals and iron in relation to biology and medicine: Some problems and concepts

Halliwell, B., & Gutteridge, J. M. C. (1986) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(86)90305-x · Cited by 2,038 · see citing works

DNA damage and oxygen radical toxicity

Imlay, J. A., & Linn, S. (1988) · Science · doi:10.1126/science.3287616 · Cited by 1,974 · see citing works

Oxygen radicals and human disease

CROSS, C. E., HALLIWELL, B., BORISH, E. T., PRYOR, W. A., AMES, B. N., SAUL, R. L., McCORD, J. M., & HARMAN, D. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-4-526 · Cited by 1,856 · see citing works

MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE

Schapira, A. H. V., Cooper, J. A. D., Dexter, D. T., Jenner, P. G., Clark, J. B., & MARSDEN, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,757 · see citing works

The effect of age on the non-haemin iron in the human brain

Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427 · see citing works

Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease

Dexter, D. T., Carter, C. J., Wells, F. R., Javoy-Agid, F., Agid, Y., Lees, A. J., Jenner, P. G., & MARSDEN, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397 · see citing works

Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains

Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383 · see citing works

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

Nicklas, W. J., Vyas, I. L., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,266 · see citing works

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149 · see citing works

Abnormalities of the electron transport chain in idiopathic parkinson's disease

Parker, W. D., Boyson, S. J., & Parks, J. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260606 · Cited by 1,061 · see citing works

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia

DEXTER, D. T., CARAYON, A., JAVOY-AGID, F., AGID, Y., WELLS, F. R., DANIEL, S. E., LEES, A. J., JENNER, P., & MARSDEN, C. D. (1991) · Brain · doi:10.1093/brain/114.4.1953 · Cited by 1,043 · see citing works

Effect of Deprenyl on the Progression of Disability in Early Parkinson's Disease

The Parkinson Study Group* (1989) · New England Journal of Medicine · doi:10.1056/nejm198911163212004 · Cited by 912 · see citing works

CENTRAL CERVICAL CORD SYNDROME AFTER HEADING A FOOTBALL

Scoppetta, C., & Vaccario, M. L. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92517-5 · Cited by 755 · see citing works

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

Sofic, E., Riederer, P. F., Heinsen, H., Beckmann, H., Reynolds, G. P., Hebenstreit, G. F., & Youdim, M. B. H. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244786 · Cited by 754 · see citing works

Parkinson's disease: A disorder due to nigral glutathione deficiency?

Perry, T. L., Godin, D. V., & Hansen, S. (1982) · Neuroscience Letters · doi:10.1016/0304-3940(82)90390-1 · Cited by 753 · see citing works

Deficiencies in Complex I subunits of the respiratory chain in Parkinson's disease

Mizuno, Y., Ohta, S., Tanaka, M., Takamiya, S., Suzuki, K., SATO, T. A., Oya, H., Ozawa, T., & Kagawa, Y. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91141-8 · Cited by 735 · see citing works

The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's Disease

Tetrud, J. W., & Langston, J. W. (1989) · Science · doi:10.1126/science.2502843 · Cited by 635 · see citing works

Free radicals, lipids and protein degradation

Wolff, S. P., Garner, A., & Dean, R. T. (1986) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(86)90228-8 · Cited by 551 · see citing works

Receptor‐mediated transcytosis of transferrin across the blood‐brain barrier

Fishman, J. B., Rubin, J. B., Handrahan, J. V., Connor, J. R., & Fine, R. E. (1987) · Journal of Neuroscience Research · doi:10.1002/jnr.490180206 · Cited by 541 · see citing works

Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis

Hirsch, E. C., Brandel, J. ‐., Galle, P., Javoy‐Agid, F., & Agid, Y. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08170.x · Cited by 537 · see citing works

The regional distribution and cellular localization of iron in the rat brain

Hill, J. M., & Switzer, R. C. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90046-0 · Cited by 486 · see citing works

Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains

Connor, J. R., Menzies, S. L., Martin, S. M. S., & Mufson, E. J. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270421 · Cited by 472 · see citing works

Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke?

Halliwell, B. B. (1989) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1989.tb01779.x · Cited by 468 · see citing works

A Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra

Saggu, H. K., Cooksey, J., Dexter, D. T., Wells, F. R., Lees, A. J., Jenner, P. G., & MARSDEN, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb11759.x · Cited by 454 · see citing works

Brain iron and ferritin in Parkinson’s and Alzheimer’s diseases

Jellinger, K., Paulus, W., Grundke-Iqbal, I., Riederer, P., & Youdim, M. B. H. (1990) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02252926 · Cited by 445 · see citing works

Brain Peroxidase and Catalase in Parkinson Disease

Ambani, L. M., Woert, M. H. V., & Murphy, S. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490440064010 · Cited by 404 · see citing works

Dopamine turnover and glutathione oxidation: implications for Parkinson disease.

Spina, M. B., & Cohen, G. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1398 · Cited by 397 · see citing works

Protection against tissue damage in vivo by desferrioxamine: What is its mechanism of action?

Halliwell, B. B. (1989) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(89)90145-7 · Cited by 378 · see citing works

Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence

Ikebe, S.-I., Tanaka, M., Ohno, K., Sato, W., Hattori, K., Kondo, T., Mizuno, Y., & Ozawa, T. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90497-b · Cited by 341 · see citing works

Toxicity of 6‐hydroxydopamine and dopamine for dopaminergic neurons in culture

Michel, P. P., & Hefti, F. F. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490260405 · Cited by 339 · see citing works

Mitochondrial oxidative phosphorylation defects in parkinson's disease

Shoffner, J. M., Watts, R. L., Juncos, J. L., Torroni, A., & Wallace, D. C. (1991) · Annals of Neurology · doi:10.1002/ana.410300304 · Cited by 333 · see citing works

Glutathione peroxidase activity in Parkinson's disease brain

Kish, S. J., Morito, C. L. H., & Hornykiewicz, O. (1985) · Neuroscience Letters · doi:10.1016/0304-3940(85)90078-3 · Cited by 301 · see citing works

The Iron Chelator Desferrioxamine (Desferal) Retards 6‐Hydroxydopamine‐Induced Degeneration of Nigrostriatal Dopamine Neurons

Ben‐Shachar, D., Eshel, G., Finberg, J. P. M., & Youdim, M. B. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb11444.x · Cited by 299 · see citing works

Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?

Youdim, M. B. H., Ben‐Shachar, D., & Riederer, P. F. (1989) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1989.tb01782.x · Cited by 292 · see citing works

The role of iron in the initiation of lipid peroxidation

Minotti, G., & Aust, S. D. (1987) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(87)90050-8 · Cited by 272 · see citing works

Decreased ferritin levels in brain in Parkinson's disease

Dexter, D. T., Carayon, A., Vidailhet, M., Ruberg, M., Agid, F., Agid, Y., Lees, A. J., Wells, F. R., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08814.x · Cited by 258 · see citing works

Oxygen Radicals and Tissue Injury

(1997) · Inflammation Research · doi:10.1007/bf03354123 · Cited by 257 · see citing works

Evidence for a defect in NADH

Parker, W. D., Boyson, S. J., LUDER, A. S., & Parks, J. K. (1990) · Neurology · doi:10.1212/wnl.40.8.1231 · Cited by 230 · see citing works

Studies on Parkinson's Disease Including X-Ray Fluorescent Spectroscopy of Formalin Fixed Brain Tissue

Earle, K. M. (1968) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-196801000-00001 · Cited by 227 · see citing works

Excitatory Amino Acid Release from Rat Hippocampal Slices as a Consequence of Free‐Radical Formation

Pellegrini-Giampietro, D. E., Cherici, G., Alesiani, M., Carlà, V., & Moroni, F. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb01187.x · Cited by 206 · see citing works

Intranigral Iron Injection Induces Behavioral and Biochemical “Parkinsonism” in Rats

Ben‐Shachar, D., & Youdim, M. B. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb06432.x · Cited by 197 · see citing works

Chronic dietary pergolide preserves nigrostriatal neuronal integrity in aged-Fischer-344 rats

Felten, D. L., Felten, S. Y., Fuller, R. W., Romano, T. D., Smalstig, E. B., Wong, D. T., & Clemens, J. A. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90048-3 · Cited by 150 · see citing works

Effect of age at onset on progression and mortality in Parkinson's disease

Diamond, S. G., Markham, C. H., Hoehn, M. M. M., MCDOWELL, F. H., & Muenter, M. D. (1989) · Neurology · doi:10.1212/wnl.39.9.1187 · Cited by 141 · see citing works

Dopamine depletion protects striatal neurons from ischemia-induced cell death

Clemens, J. A., & Phebus, L. A. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90463-8 · Cited by 140 · see citing works

The effect of melanin on iron associated decomposition of hydrogen peroxide

Pilas, B., Sarna, T., Kalyanaraman, B., & Swartz, H. M. (1988) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(88)90049-4 · Cited by 139 · see citing works

Preservation of the substanitia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four‐year period

Quinn, N. P., Parkes, D., Janota, I., & MARSDEN, C. D. (1986) · Movement Disorders · doi:10.1002/mds.870010109 · Cited by 132 · see citing works

Scientific Basis for the Treatment of Parkinson??s Disease

Wolters, E. C. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200607000-00011 · Cited by 131 · see citing works

Nigrostriatal Dopaminergic Neurons Remain Undamaged in Rats Given High Doses of l ‐DOPA and Carbidopa Chronically

Perry, T. L., Yong, V. W., Ito, M., Foulks, J. G., Wall, R. A., Godin, D. V., & Clavier, R. M. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb12834.x · Cited by 130 · see citing works

Long‐term administration of L‐DOPA does not damage dopaminergic neurons in the mouse

Hefti, F. F., Melamed, E., Bhawan, J., & Wurtman, R. J. (1981) · Neurology · doi:10.1212/wnl.31.9.1194 · Cited by 126 · see citing works

Hemoglobin-mediated oxidant damage to the central nervous system requires endogenous ascorbate.

Sadrzadeh, S. M. H., & Eaton, J. W. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113759 · Cited by 124 · see citing works

Imaging of the aging brain. Part II. Pathologic conditions.

Drayer, B. P. (1988) · Radiology · doi:10.1148/radiology.166.3.3277248 · Cited by 117 · see citing works

Parkinsonism and Aging, 1989

Fishman, L. M. (1990) · Topics in Geriatric Rehabilitation · doi:10.1097/00013614-199004000-00018 · Cited by 114 · see citing works

Effect of ferritin-containing fractions with different iron loading on lipid peroxidation

Gutteridge, J. M. C., Halliwell, B. B., Treffry, A., Harrison, P. M., & Blake, D. R. (1983) · Biochemical Journal · doi:10.1042/bj2090557 · Cited by 113 · see citing works

Mitochondrial DNA analysis in Parkinson's disease

Schapira, A. H. V., Holt, I. J., Sweeney, M. G., Harding, A. E., Jenner, P. G., & MARSDEN, C. D. (1990) · Movement Disorders · doi:10.1002/mds.870050406 · Cited by 112 · see citing works

Combined bromocriptine‐levodopa therapy early in Parkinson's disease

Rinne, U. K. (1985) · Neurology · doi:10.1212/wnl.35.8.1196 · Cited by 111 · see citing works

Iron chelation prevents tissue injury following ischemia

Aust, S. D., & White, B. C. (1985) · Advances in free radical biology and medicine · doi:10.1016/8755-9668(85)90003-1 · Cited by 109 · see citing works

Glutathione in Parkinson's disease: A link between oxidative stress and mitochondrial damage?

Monte, D. A. D., Chan, P., & Sandy, M. S. (1992) · Annals of Neurology · doi:10.1002/ana.410320719 · Cited by 107 · see citing works

Iron induces degeneration of nigrostriatal neurons

Sengstock, G. J., Olanow, C. W., Dunn, A. J., & Arendash, G. W. (1992) · Brain Research Bulletin · doi:10.1016/0361-9230(92)90118-h · Cited by 90 · see citing works

Exposure of striatal [corrected] synaptosomes to L-dopa increases levels of oxidized glutathione.

Spina, M. B., & Cohen, G. (1988) · PubMed · Cited by 77 · see citing works

Modulation by neuromelanin of the availability and reactivity of metal ions

Swartz, H. M., Sarna, T., & Zecca, L. (1992) · Annals of Neurology · doi:10.1002/ana.410320712 · Cited by 73 · see citing works

Does selegiline monotherapy in Parkinson's disease act by symptomatic or protective mechanisms?

Olanow, C. W., & Calne, D. B. (1992) · PubMed · Cited by 59 · see citing works

A Rationale for Dopamine Agonists as Primary Therapy for Parkinson’s Disease

Olanow, C. W. (1992) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100041469 · Cited by 54 · see citing works

Central Mechanisms and Levodopa Response Fluctuations in Parkinsonʼs Disease

Mouradian, M. M., & Chase, T. N. (1988) · Clinical Neuropharmacology · doi:10.1097/00002826-198808000-00007 · Cited by 48 · see citing works

IN PRAISE OF PEROXIDATION

Dormandy, T. L. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90535-1 · Cited by 31 · see citing works

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · see citing works

Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader11Mention of a trade name, proprietary product, or specific equipment does not constitute a guarantee by the United States Department of Agriculture and does not imply its approval to the exclusion of other products that may be suitable.

Wang, H., & Joseph, J. A. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00107-0 · Cited by 2,355 · see citing works

Hydrogen peroxide mediates amyloid β protein toxicity

Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074 · see citing works

Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen

Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683 · see citing works

Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease

Jack, C. R., Petersen, R. C., Xu, Y. C., Waring, S. C., O'Brien, P. C., Tangalos, E. G., Smith, G. E., Ivnik, R. J., & Kokmen, E. (1997) · Neurology · doi:10.1212/wnl.49.3.786 · Cited by 1,128 · see citing works

Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation

Joseph, J. A., Shukitt-Hale, B., Denisova, N. A., Bielinski, D., Martin, A., McEwen, J. J., & Bickford, P. C. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-18-08114.1999 · Cited by 980 · see citing works

Nanoparticles in cellular drug delivery

Faraji, A. H., & Wipf, P. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.02.043 · Cited by 907 · see citing works

A radical hypothesis for neurodegeneration

Olanow, C. W. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90070-3 · Cited by 722 · see citing works

Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death

Bains, J. S., & Shaw, C. A. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00045-3 · Cited by 716 · see citing works

Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease

Boka, G., Anglade, P., Wallach, D., Javoy-Agid, F., Agid, Y., & Hirsch, É. C. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90684-x · Cited by 591 · see citing works

Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain

Kim, H., Park, S., Zhou, J.-L., Taglialatela, G., Chung, K., Coggeshall, R., & Chung, J.-M. (2004) · Pain · doi:10.1016/j.pain.2004.06.008 · Cited by 451 · see citing works

Cardiac Sympathetic Denervation in Parkinson Disease

Goldstein, D. S., Holmes, C., Li, S.-T., Bruce, S., Metman, L. V., & Cannon, R. O. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-5-200009050-00009 · Cited by 372 · see citing works

Reversing the deleterious effects of aging on neuronal communication and behavior: beneficial properties of fruit polyphenolic compounds

Joseph, J. A., Shukitt‐Hale, B., & Casadesús, G. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.313s · Cited by 368 · see citing works

The effect of deprenyl and levodopa on the progression of Parkinson's disease

Olanow, C. W., Hauser, R. A., Gauguster, L., Malapira, T., Koller, W. C., Hubble, J. P., Busenbark, K. L., Lilienfeld, D. E., & Esterlitz, J. (1995) · Annals of Neurology · doi:10.1002/ana.410380512 · Cited by 334 · see citing works

Improving the Survival of Grafted Dopaminergic Neurons: A Review over Current Approaches

Brundin, P., Karlsson, J., Emgård, M., Schierle, G. S. K., Hansson, O., Petersén, Å., & Castilho, R. F. (2000) · Cell Transplantation · doi:10.1177/096368970000900205 · Cited by 331 · see citing works

Mice with DNA repair gene (ERCC-1) deficiency have elevated levels of p53, liver nuclear abnormalities and die before weaning

McWhir, J., Selfridge, J., Harrison, D. J., Squires, S., & Melton, D. W. (1993) · Nature Genetics · doi:10.1038/ng1193-217 · Cited by 321 · see citing works

Melatonin Antioxidative Defense: Therapeutical Implications for Aging and Neurodegenerative Processes

Pandi-Perumal, S. R., BaHammam, A. S., Brown, G. M., Spence, D. W., Bharti, V. K., Kaur, C., Hardeland, R., & Cardinali, D. P. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9337-4 · Cited by 320 · see citing works

Role of metal dyshomeostasis in Alzheimer's disease

Bonda, D., Lee, H., Blair, J. A., Zhu, X., Perry, G. L., & Smith, M. A. (2011) · Metallomics · doi:10.1039/c0mt00074d · Cited by 316 · see citing works

Iron and mechanisms of emotional behavior

Kim, J., & Wessling‐Resnick, M. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.07.003 · Cited by 314 · see citing works

Microglia enhance β‐amyloid peptide‐induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species

Qin, L., Liu, Y., Cooper, C. L., Liu, B., Wilson, B. C., & Hong, J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01210.x · Cited by 290 · see citing works

Are mitochondria critical in the pathogenesis of Alzheimer's disease?

Reddy, P. H., & Beal, M. F. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.03.004 · Cited by 289 · see citing works

The Effects of Methamphetamine on the Production of Free Radicals and Oxidative Stress

Yamamoto, B. K., & Zhu, W. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37769-9 · Cited by 281 · see citing works

A detailed analysis of hydrogen peroxide-induced cell death in primary neuronal culture

Whittemore, E. R., Loo, D. T., Watt, J. A., & Cotmans, C. W. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00108-u · Cited by 265 · see citing works

Reactive oxygen species (ROS) are involved in enhancement of NMDA-receptor phosphorylation in animal models of pain

Gao, X. M., Kim, H. K., Chung, J. M., & Chung, K. (2007) · Pain · doi:10.1016/j.pain.2007.01.011 · Cited by 253 · see citing works

Cerebral amyloid angiopathy

Greenberg, S. M. (1998) · Neurology · doi:10.1212/wnl.51.3.690 · Cited by 245 · see citing works

Parkinson Disease, the Effect of Levodopa, and the ELLDOPA Trial

Fahn, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.529 · Cited by 246 · see citing works

The neuroprotective role of melatonin in neurological disorders

Alghamdi, B. S. A. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24220 · Cited by 234 · see citing works

Oxidative Stress Associated with Neuronal Apoptosis in Experimental Models of Epilepsy

Armenta, M. M., Nava-Ruíz, C., Juárez-Rebollar, D., Rodrı́guez-Martı́nez, E., & Gómez, P. Y. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/293689 · Cited by 228 · see citing works

Tumor Necrosis Factor α Is Toxic to Embryonic Mesencephalic Dopamine Neurons

McGuire, S. O., Ling, Z. D., Lipton, J. W., Sortwell, C. E., Collier, T. J., & Carvey, P. M. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7688 · Cited by 222 · see citing works

Ginsenoside Rg1 Prevents Cognitive Impairment and Hippocampus Senescence in a Rat Model of D-Galactose-Induced Aging

Zhu, J., Mu, X., Zeng, J., Xu, C., Liu, J., Zhang, M., Li, C., Chen, J., Li, T.-Y., & Wang, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101291 · Cited by 219 · see citing works

Berry Fruit Supplementation and the Aging Brain

Shukitt‐Hale, B., Lau, F. C., & Joseph, J. A. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf072505f · Cited by 218 · see citing works

Evidence for mitochondrial dysfunction in Parkinson's disease—a critical appraisal

Schapira, A. H. V. (1994) · Movement Disorders · doi:10.1002/mds.870090202 · Cited by 218 · see citing works

The beneficial effects of fruit polyphenols on brain aging

Lau, F. C., Shukitt-Hale, B., & Joseph, J. A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.08.007 · Cited by 217 · see citing works

Blueberry Supplemented Diet: Effects on Object Recognition Memory and Nuclear Factor-kappa B Levels in Aged Rats

Goyarzu, P., Malin, D. H., Lau, F. C., Taglialatela, G., Moon, W. D., Jennings, R., Moy, E., Moy, D. M., Lippold, S., Shukitt‐Hale, B., et al. (2004) · Nutritional Neuroscience · doi:10.1080/10284150410001710410 · Cited by 213 · see citing works

Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy

van den Bent, M. J., Kros, J. M., Heimans, J. J., Pronk, L. C., van Groeningen, C. J., Krouwer, H. G. J., TAPHOORN, M. J. B., Zonnenberg, B. A., Tijssen, C. C., Twijnstra, A., et al. (1998) · Neurology · doi:10.1212/wnl.51.4.1140 · Cited by 206 · see citing works

A multicenter double‐blind placebo‐controlled trial of pergolide as an adjunct to sinemet® in Parkinson's disease

Olanow, C. W., Fahn, S., Muenter, M. D., Klawans, H. L., Hurtig, H. I., Stern, M., Shoulson, I., Kurlan, R., Grimes, J. D., Jankovic, J. J., et al. (1994) · Movement Disorders · doi:10.1002/mds.870090107 · Cited by 204 · see citing works

Risk of cancer from azathioprine therapy in multiple sclerosis

Confavreux, C., Saddier, P., Grimaud, J., Moreau, T., Adeleine, P., & Aimard, G. (1996) · Neurology · doi:10.1212/wnl.46.6.1607 · Cited by 203 · see citing works

Copernicus revisited: amyloid beta in Alzheimer's disease.

Josepha, J. A., Shukitt-Hale, B., Denisova, N., Martín, A., Perry, G., & Smith, M. A. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00211-6 · Cited by 209 · see citing works

Grape Juice, Berries, and Walnuts Affect Brain Aging and Behavior

Joseph, J. A., Shukitt‐Hale, B., & Willis, L. (2009) · Journal of Nutrition · doi:10.3945/jn.109.108266 · Cited by 202 · see citing works

Curcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell model

Wang, M. S., Boddapati, S. P., Emadi, S., & Sierks, M. R. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-57 · Cited by 200 · see citing works

Aluminium and the risk for alzheimer's disease

McLachlan, D. R. C. (1995) · Environmetrics · doi:10.1002/env.3170060303 · Cited by 195 · see citing works

Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases

Ramalingam, M., & Kim, S. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-011-0758-7 · Cited by 193 · see citing works

Dopamine D2‐type agonists protect mesencephalic neurons from glutamate neurotoxicity: Mechanisms of neuroprotective treatment against oxidative stress

Sawada, H., Ibi, M., Kihara, T., Urushitani, M., Akaike, A., Kimura, J., & Shimohama, S. (1998) · Annals of Neurology · doi:10.1002/ana.410440117 · Cited by 193 · see citing works

Brain Iron Metabolism Dysfunction in Parkinson’s Disease

Jiang, H. F., Wang, J., Rogers, J. T., & Xie, J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9879-1 · Cited by 183 · see citing works

Poor and protracted myelination as a contributory factor to neurodegenerative disorders

Braak, H., & Tredici, K. D. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.04.001 · Cited by 175 · see citing works

Curcumin affords neuroprotection and inhibits α-synuclein aggregation in lipopolysaccharide-induced Parkinson’s disease model

Sharma, N., & Nehru, B. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0402-8 · Cited by 177 · see citing works

Oxidative stress and apoptosis in neurodegeneration

Gorman, A. M., McGowan, A. J., O’Neill, C., & Cotter, T. G. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00097-4 · Cited by 174 · see citing works

Mitochondrial dysfunction in glaucoma and emerging bioenergetic therapies

Lee, S., Bergen, N. J. V., Kong, G. Y. X., Chrysostomou, V., Waugh, H. S., O’Neill, E. C., Crowston, J. G., & Trounce, I. A. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.07.015 · Cited by 166 · see citing works

The Role of Oxidative Stress, Metabolic Compromise, and Inflammation in Neuronal Injury Produced by Amphetamine-Related Drugs of Abuse

Yamamoto, B. K., & Raudensky, J. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9121-7 · Cited by 167 · see citing works

Nanoparticle and other metal chelation therapeutics in Alzheimer disease

Liu, G., Garrett, M. R., Men, P., Zhu, X., Perry, G. L., & Smith, M. A. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.06.006 · Cited by 160 · see citing works

Oxidative damage caused by free radicals produced during catecholamine autoxidation: Protective effects of O-methylation and melatonin

Miller, J. W., Selhub, J., & Joseph, J. A. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(96)00033-0 · Cited by 157 · see citing works

Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study

Oestreicher, E., Sengstock, G. J., Riederer, P., Olanow, C. W., Dunn, A. J., & Arendash, G. W. (1994) · Brain Research · doi:10.1016/0006-8993(94)90833-8 · Cited by 156 · see citing works

Oxidative Stress and Parkinson's Diseasea

Owen, A., Schapira, A. H. V., Jenner, P. G., & MARSDEN, C. D. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb39064.x · Cited by 154 · see citing works

Mitochondrial Oxidative Damage in Aging and Alzheimer′s Disease: Implications for Mitochondrially Targeted Antioxidant Therapeutics

Reddy, P. H. (2006) · BioMed Research International · doi:10.1155/jbb/2006/31372 · Cited by 153 · see citing works

Oxidative and nitrative alpha‐synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies

Schildknecht, S., Gerding, H. R., Karreman, C., Drescher, M., Lashuel, H. A., Outeiro, T. F., Di Monte, D. A., & Leist, M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12226 · Cited by 148 · see citing works

Induction of NF-κB Activity during Haloperidol-Induced Oxidative Toxicity in Clonal Hippocampal Cells: Suppression of NF-κB and Neuroprotection by Antioxidants

Post, A., Holsboer, F., & Behl, C. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08236.1998 · Cited by 146 · see citing works

Oxidative Stress and Inflammation in Brain Aging: Nutritional Considerations

Joseph, J. A., Shukitt‐Hale, B., Casadesús, G., & Fisher, D. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6967-4 · Cited by 137 · see citing works

Increased Iron in the Substantia Nigra Compacta of the MPTP‐Lesioned Hemiparkinsonian African Green Monkey: Evidence from Proton Microprobe Elemental Microanalysis

Temlett, J. A., Landsberg, J. P., Watt, F., & Orime, G. W. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62010134.x · Cited by 137 · see citing works

Excitotoxicity, Oxidative Stress, and the Neuroprotective Potential of Melatonin

Skaper, S. D., Floreani, M., Ceccon, M., Facci, L., & Giusti, P. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07985.x · Cited by 135 · see citing works

Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease

Saravanan, K. S., Madathil, S. K., & Mohanakumar, K. P. (2005) · Brain Research · doi:10.1016/j.brainres.2005.04.051 · Cited by 134 · see citing works

Alzheimer's disease

Duara, R., Barker, W., Lopez-Alberola, R., Loewenstein, D., Grau, L. B., Gilchrist, D. M., Sevush, S., & George‐Hyslop, P. S. (1996) · Neurology · doi:10.1212/wnl.46.6.1575 · Cited by 132 · see citing works

Caffeinated coffee, decaffeinated coffee, and the phenolic phytochemical chlorogenic acid up-regulate NQO1 expression and prevent H2O2-induced apoptosis in primary cortical neurons

Kim, J., Lee, S., Shim, J., Kim, H. W., Kim, J., Jang, Y. J., Yang, H. S., Park, J., Choi, S. H., Yoon, J. H., et al. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.02.004 · Cited by 131 · see citing works

Metabolic and Molecular Bases of Menkes Disease and Occipital Horn Syndrome

Kaler, S. G. (1998) · Pediatric and Developmental Pathology · doi:10.1007/s100249900011 · Cited by 131 · see citing works

Diagnosis and therapy of Menkes syndrome, a genetic form of copper deficiency

Kaler, S. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.5.1029s · Cited by 129 · see citing works

Pro-apoptotic gene expression mediated by the p38 mitogen-activated protein kinase signal transduction pathway

Zutter, G. S. D., & Davis, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111027698 · Cited by 128 · see citing works

Clinical–Pathological study of levodopa complications

Rajput, A. H., Fenton, M. E., Birdi, S., Macaulay, R. J. B., George, D. H., Rozdilsky, B., Ang, L. C., Senthilselvan, A., & Hornykiewicz, O. (2002) · Movement Disorders · doi:10.1002/mds.10031 · Cited by 126 · see citing works

Analgesic effect of vitamin E is mediated by reducing central sensitization in neuropathic pain

Kim, H. K., Kim, J. H., Gao, X. M., Zhou, J.-L., Lee, I., Chung, K., & Chung, J. M. (2006) · Pain · doi:10.1016/j.pain.2006.01.013 · Cited by 124 · see citing works

Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction

Sloan, M. A., Price, T. R., Petito, C. K., Randall, A. M. Y., Solomon, R. E., Terrin, M. L., Gore, J. M., Collen, D., Kleiman, N. S., Feit, F., et al. (1995) · Neurology · doi:10.1212/wnl.45.4.649 · Cited by 122 · see citing works

Elemental imbalances in the olfactory pathway in Alzheimer's disease

Samudralwar, D. L., Diprete, C. C., Ni, B. F., Ehmann, W. D., & Markesbery, W. R. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00018-w · Cited by 116 · see citing works

The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: A hypothesis

Enochs, W. S., Sarna, T., Zecca, L., Riley, P. A., & Swartz, H. M. (1994) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02260963 · Cited by 116 · see citing works

Botulinum toxin treatment of essential head tremor

Pahwa, R., Busenbark, K., Swanson-Hyland, E. F., Dubinsky, R. M., Hubble, J. P., Gray, C., & Koller, W. C. (1995) · Neurology · doi:10.1212/wnl.45.4.822 · Cited by 114 · see citing works

Selenium effectively inhibits ROS-mediated apoptotic neural precursor cell death in vitro and in vivo in traumatic brain injury

Yeo, J. E., & Kang, S. K. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.09.004 · Cited by 115 · see citing works

Therapeutic potential of melatonin and its analogs in Parkinson’s disease: focus on sleep and neuroprotection

Srinivasan, V., Cardinali, D. P., Srinivasan, U. S., Kaur, C., Brown, G. M., Spence, D. W., Hardeland, R., & Pandi-Perumal, S. R. (2011) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285611406166 · Cited by 113 · see citing works

Fruit Polyphenols and Their Effects on Neuronal Signaling and Behavior in Senescence

Joseph, J. A., Shukitt‐Hale, B., & Lau, F. C. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1395.052 · Cited by 114 · see citing works

Menkes Disease

Kaler, S. G. (1994) · Advances in Pediatrics · doi:10.1016/s0065-3101(24)00096-3 · Cited by 114 · see citing works

Blueberry supplemented diet reverses age-related decline in hippocampal HSP70 neuroprotection

Galli, R. L., Bielinski, D. F., Szprengiel, A., Shukitt‐Hale, B., & JOSEPH, J. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.01.017 · Cited by 113 · see citing works

Hydrogen Peroxide Induces Intracellular Calcium Overload by Activation of a Non-selective Cation Channel in an Insulin-secreting Cell Line

Herson, P. S., Lee, K., Pinnock, R. D., Hughes, J. M., & Ashford, M. L. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.833 · Cited by 111 · see citing works

The beneficial effects of berries on cognition, motor behaviour and neuronal function in ageing

Shukitt‐Hale, B., Bielinski, D. F., Lau, F. C., Willis, L., Carey, A. N., & Joseph, J. A. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515003451 · Cited by 110 · see citing works

Gene Regulation by Reactive Oxygen Species

Cimino, F., Esposito, F., Ammendola, R., & Russo, T. (1997) · Current topics in cellular regulation · doi:10.1016/s0070-2137(97)80005-2 · Cited by 107 · see citing works

Neuroprotective effects of estradiol in mesencephalic dopaminergic neurons

Sawada, H., & Shimohama, S. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00059-7 · Cited by 103 · see citing works

Drug delivery strategies for Alzheimer's disease treatment

Stefano, A. D., Iannitelli, A., Laserra, S., & Sozio, P. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.561311 · Cited by 105 · see citing works

Oxidative stress protection and vulnerability in aging: putative nutritional implications for intervention

Joseph, J. A., Denisova, N. A., Bielinski, D. F., Fisher, D. R., & Shukitt‐Hale, B. (2000) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(00)00128-7 · Cited by 104 · see citing works

Phenolic antioxidants attenuate hippocampal neuronal cell damage against kainic acid induced excitotoxicity

Parihar, M. S., & Hemnani, T. (2003) · Journal of Biosciences · doi:10.1007/bf02970142 · Cited by 102 · see citing works

Melatonin in mitochondrial dysfunction and related disorders

Srinivasan, V., Spence, D. W., Pandi-Perumal, S. R., Brown, G. M., & Cardinali, D. P. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/326320 · Cited by 100 · see citing works

Melatonin maintains glutathione homeostasis in kainic acid‐exposed rat brain tissues

Floreani, M., Skaper, S. D., Facci, L., Lipartiti, M., & Giusti, P. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.14.9409550 · Cited by 100 · see citing works

Reactive Oxygen Species as Mediators of Photoreceptor Apoptosisin Vitro

Carmody, R. J., McGowan, A. J., & Cotter, T. G. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4421 · Cited by 98 · see citing works

Protective effects of atypical antipsychotic drugs on PC12 cells after serum withdrawal

Bai, O., Wei, Z., Lu, W., Bowen, R., Keegan, D. A., & Li, X. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10290 · Cited by 98 · see citing works

Antioxidant capacity of the neurohormone melatonin

Sofic, E., Rimpapa, Z., Kundurović, Z., Šapčanin, A., Tahirović, I., Rustembegovic, A., & Cao, G. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-004-0270-4 · Cited by 97 · see citing works

Dietary supplementation with fruit polyphenolics ameliorates age-related deficits in behavior and neuronal markers of inflammation and oxidative stress

Shukitt‐Hale, B., Galli, R. L., Meterko, V., Carey, A. N., Bielinski, D. F., McGhie, T. K., & Joseph, J. A. (2005) · AGE · doi:10.1007/s11357-005-4004-9 · Cited by 97 · see citing works

Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexole

Carvey, P. M., Pieri, S., & Ling, Z. D. (1997) · Journal of Neural Transmission · doi:10.1007/bf01273182 · Cited by 97 · see citing works

Simultaneous edited MRS of GABA and glutathione

Saleh, M. G., Oeltzschner, G., Chan, K. L., Puts, N. A. J., Mikkelsen, M. E., Schär, M., Harris, A. D., & Edden, R. A. E. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.07.056 · Cited by 96 · see citing works

Decreases in protective enzymes correlates with increased oxidative damage in the aging mouse brain

Mo, J. Q., Hom, D. G., & Andersen, J. K. (1995) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(95)01586-o · Cited by 96 · see citing works

Nanoparticle and Iron Chelators as a Potential Novel Alzheimer Therapy

Liu, G., Men, P., Perry, G. L., & Smith, M. A. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-029-8_8 · Cited by 95 · see citing works

Apoptosis modulators in the therapy of neurodegenerative diseases

Deigner, H., Haberkorn, U., & Kinscherf, R. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.4.747 · Cited by 93 · see citing works

Adenovirus in the brain: recent advances of gene therapy for neurodegenerative diseases

Barkats, M., Bilang‐Bleuel, A., Buc‐Caron, M., Castel-Barthe, M. N., Corti, O., Finiels, F., Horellou, P., Revah, F., Sabaté, O., & Mallet, J. J. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00028-8 · Cited by 94 · see citing works

Increased apoptosis, p53 up-regulation, and cerebellar neuronal degeneration in repair-deficient Cockayne syndrome mice

Laposa, R. R., Huang, E. J., & Cleaver, J. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610619104 · Cited by 92 · see citing works

Genetic and environmental risk factors in Parkinson’s disease

Veldman, B. A. J., Wijn, A. M., Knoers, N. V. A. M., Praamstra, P., & Horstink, M. W. I. M. (1998) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(98)00009-2 · Cited by 91 · see citing works

The role of dopamine agonists in early Parkinson's disease

Watts, R. L. (1997) · Neurology · doi:10.1212/wnl.49.1_suppl_1.s34 · Cited by 88 · see citing works

Evidence for oxidative stress in Pick disease and corticobasal degeneration

Castellani, R. J., Smith, M. A., Richey, P. L., Kalaria, R. N., Gambetti, P., & Perry, G. L. (1995) · Brain Research · doi:10.1016/0006-8993(95)00535-x · Cited by 86 · see citing works

Different action on dopamine catabolic pathways of two endogenous 1,2,3,4‐tetrahydroisoquinolines with similar antidopaminergic properties

Antkiewicz‐Michaluk, L., Michaluk, J., Mokrosz, M. J., Romańska, I., Lorenc‐Koci, E., Ohta, S., & Vetulani, J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00391.x · Cited by 85 · see citing works

Oxidation reactions in Parkinson's disease.

Olanow, C. W. (1990) · PubMed · Cited by 245 · see citing works

Dopaminergic cell death in Parkinson’s disease: a role of iron?

Javoy-Agid, F., & Faucheux, B. A. (1993) · Key topics in brain research · doi:10.1007/978-3-7091-9322-8_6

The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it

Fahn, S., & Cohen, G. (1992) · Annals of Neurology · doi:10.1002/ana.410320616 · Cited by 927 · see citing works

Oxidative Stress in Parkinsonʼs Disease

Olanow, C. W. (1997) · Clinical Neuropharmacology · doi:10.1097/00002826-199720001-00002 · Cited by 4 · see citing works

Parkinsons disease and oxygen free radicals

Feng, W. (2000) · Zhongguo yaolixue tongbao · Cited by 1 · see citing works